Find out how Glivec has changed the normal course of cancer for patients with Ph+CML and KIT+ GIST by inhibiting the molecular causes of these diseases.
Introgen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the ...
Directly to main navigation Directly to content MDC Berlin Buch 1: Home I 2: Contact I 3: Impressum I 4: Sitemap I Print '); --> I 5: Deutsch Main navigation ...
Directly to main navigation Directly to content MDC Berlin Buch 1: Home I 2: Contact I 3: Impressum I 4: Sitemap I Print '); --> I 5: Deutsch Main navigation ...